Advertisement
Advertisement
July 16, 2012
Vascular Solutions Launches Gel-Block Embolization Product
July 9, 2012—Vascular Solutions, Inc. (Minneapolis, MN) announced the United States launch of its Gel-Block embolization pledgets for use in the treatment of hypervascular tumors and arteriovenous malformations. Gel-Block received 510(k) clearance from the US Food and Drug Administration in May. CE Mark approval and other foreign registrations for international launch are pending.
In a press release, Vascular Solutions stated that Gel-Block consists of preformed, radially compressed, precisely sized pledgets of gelatin foam. It is available in three sizes and packaged into ready-to-use tubes for delivery through standard catheters with inner diameters as small as 0.021 inch. After contact with blood, the pledget almost immediately expands to five times its compressed size. This radial crimping process ensures that upon expansion, the width (but not the length) of the pledget will grow, which allows for controlled and predictable delivery within the vessel, noted Vascular Solutions.
Advertisement
Advertisement
